These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1378572)

  • 1. Neurochemical changes in the rat brain after intraventricular administration of tryptamine-4,5-dione.
    Chen JC; Schnepper PW; To A; Volicer L
    Neuropharmacology; 1992 Mar; 31(3):215-9. PubMed ID: 1378572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione.
    Chen JC; Crino PB; Schnepper PW; To AC; Volicer L
    J Pharmacol Exp Ther; 1989 Jul; 250(1):141-8. PubMed ID: 2473186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic properties of a serotonin oxidation product: possible role in Alzheimer's disease.
    Volicer L; Chen JC; Crino PB; Vogt BA; Fishman J; Rubins J; Schenepper PW; Wolfe N
    Prog Clin Biol Res; 1989; 317():453-65. PubMed ID: 2481322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
    Dewar KM; Grondin L; Carli M; Lima L; Reader TA
    J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxic effects of partially oxidized serotonin: tryptamine-4,5-dione.
    Crino PB; Vogt BA; Chen JC; Volicer L
    Brain Res; 1989 Dec; 504(2):247-57. PubMed ID: 2598027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of tryptophan hydroxylase and content of indolamines in discrete brain regions after a long-term hypoxic exposure in the rat.
    Poncet L; Denoroy L; Dalmaz Y; Pequignot JM
    Brain Res; 1997 Aug; 765(1):122-8. PubMed ID: 9310402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional studies of serotonin and dopamine metabolism and quantification of serotonin uptake sites in human cerebral cortex.
    Parsons B; Roxas A; Huang YY; Dwork A; Stanley M
    J Neural Transm Gen Sect; 1992; 87(1):63-75. PubMed ID: 1371391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat.
    Zhou D; Grecksch G; Becker A; Frank C; Pilz J; Huether G
    J Neurosci Res; 1998 Oct; 54(1):109-16. PubMed ID: 9778154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase).
    Huang XM; Johnson MP; Nichols DE
    Eur J Pharmacol; 1991 Jul; 200(1):187-90. PubMed ID: 1722753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic methamphetamine administration on tryptophan hydroxylase activity, [3H]serotonin synaptosomal uptake, and serotonin metabolism in rat brain following systemic tryptophan loading.
    Trulson ME; Trulson VM
    Neuropharmacology; 1982 Jun; 21(6):521-7. PubMed ID: 6180346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').
    O'Shea E; Granados R; Esteban B; Colado MI; Green AR
    Neuropharmacology; 1998 Jul; 37(7):919-26. PubMed ID: 9776387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.
    Colado MI; Green AR
    Eur J Pharmacol; 1995 Jul; 280(3):343-6. PubMed ID: 8566105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR; Peroutka SJ
    Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin.
    Fishman JB; Rubins JB; Chen JC; Dickey BF; Volicer L
    J Neurochem; 1991 Jun; 56(6):1851-4. PubMed ID: 1902871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.
    O'Shea E; Orio L; Escobedo I; Sanchez V; Camarero J; Green AR; Colado MI
    Br J Pharmacol; 2006 Jul; 148(6):778-85. PubMed ID: 16770327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.